Literature DB >> 16212892

Preparation of ChIL-2 and IBDV VP2 fusion protein by baculovirus expression system.

Yan Liu1, Yongwei Wei, Xiaofeng Wu, Lian Yu.   

Abstract

This study aims to produce an effective subunit vaccine against infectious bursal disease virus (IBDV). The genes of chicken interleukin-2 (ChIL-2) and IBDV viral protein 2 (VP2) were amplified and fused by splice overlap extension-polymerase chain reaction (SOE-PCR). The fusion gene was digested by EcoR I/Kpn I and inserted into pBacPAK8 vector, resulting in recombinant transfer plasmid pBacPakVP2-IL2. The recombinant plasmid was transfected into Sf-9 cells accompanied with hybrid nuclear polyhedrosis virus (HyNPV) genome DNA and lipofectin. Plaque-purification indicated that we had got the recombinant Hy-VP2-IL2. Fusion protein VP2-IL2 was expressed effectively both in insect cells and bombyx mori. The expression of fusion protein was confirmed by ELISA, SDS-PAGE and Western blotting assay, respectively. This efficient system allows us to meet the need for inexpensive vaccines required by the poultry industry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212892

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  2 in total

1.  Gingyo-san enhances immunity and potentiates infectious bursal disease vaccination.

Authors:  Che-Ming Hung; Chia-Chou Yeh; Kowit-Yu Chong; Hsiao-Ling Chen; Jiun-Yu Chen; Shung-Te Kao; Chih-Ching Yen; Ming-Hsien Yeh; Maw-Sun Lin; Chuan-Mu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-25       Impact factor: 2.629

2.  Development of a Novel Assay Based on Plant-Produced Infectious Bursal Disease Virus VP3 for the Differentiation of Infected From Vaccinated Animals.

Authors:  Alessio Bortolami; Marcello Donini; Carla Marusic; Chiara Lico; Charifa Drissi Touzani; Federica Gobbo; Elisa Mazzacan; Andrea Fortin; Valentina Maria Panzarin; Francesco Bonfante; Selene Baschieri; Calogero Terregino
Journal:  Front Plant Sci       Date:  2021-12-07       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.